Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning (Allergen) - Crave Stevia brand chocolate products recalled due to undeclared milk


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/crave-stevia-brand-chocolate-products-recalled-due-undeclared-milk

OTTAWA, ON, July 15, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC

Codes

Crave Stevia   

Almond All Natural Chocolate

80 g

85 g

8 84063 00088 3

All codes where milk is
not declared on the label   

Crave Stevia

Dark All Natural Chocolate

80 g

85 g

8 84063 00085 2

All codes where milk is
not declared on the label

Crave Stevia

Mint All Natural Chocolate

80 g

85 g

8 84063 00084 5

All codes where milk is
not declared on the label

Crave Stevia

Sea Salt All Natural Chocolate

80 g

85 g

8 84063 00083 8

All codes where milk is
not declared on the label

Crave Stevia

Sprinkles All Natural Chocolate   

80 g

85 g

8 84063 00118 7

All codes where milk is
not declared on the label

Crave Stevia

Chocolate Chips

200 g   

8 84063 00069 2

All codes where milk is
not declared on the label

Issue

The affected products are being recalled from the marketplace because they may contain milk which is not declared on the label.

The recalled products have been sold in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, and Nova Scotia, and may have been distributed in other provinces and territories. They have also been sold online.

What you should do

Learn more:

Background

This recall was triggered by Canadian Food Inspection Agency test results.

There have been no reported reactions associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...



News published on and distributed by: